ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,342Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 2680

$1.17M Total Retail Price of All Prescriptions

Rank: 37 out of 2680

503 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 503 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 503 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 22,313 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 834 834 1 7
FAMOTIDINE 688 678 2 65
LEVOTHYROXINE SODIUM 687 675 3 4
POLYETHYLENE GLYCOL 3350 639 600 4 55
OMEPRAZOLE 633 622 5 2
LISINOPRIL 606 583 6 5
METOPROLOL TARTRATE 539 538 7 8
ATENOLOL 497 491 8 14
DONEPEZIL HCL 477 477 9 28
CITALOPRAM HBR 456 438 10 22
HYDROCODONE-ACETAMINOPHEN 427 419 S3 11 13
AMLODIPINE BESYLATE 380 372 12 3
NAMENDA 349 338 13 43
METFORMIN HCL 323 306 14 6
HYDROCHLOROTHIAZIDE 310 291 15 9
JANTOVEN 307 289 16 81
WARFARIN SODIUM 294 268 17 12
LANTUS SOLOSTAR 277 273 18 68
RISPERIDONE 277 277 18 67
QUETIAPINE FUMARATE 272 267 20 72
SERTRALINE HCL 271 271 21 23
TAMIFLU 265 253 10 22 136
SIMVASTATIN 258 248 23 1
MIRTAZAPINE 248 248 24 48
METOPROLOL SUCCINATE 241 230 25 11
LANTUS 230 214 26 70
CARBIDOPA-LEVODOPA 219 219 27 88
DIGOXIN 216 216 28 59
TAMSULOSIN HCL 208 166 29 25
GABAPENTIN 204 191 30 21
LEVETIRACETAM 198 155 31 94
LOSARTAN POTASSIUM 194 179 32 18
CARVEDILOL 188 188 33 27
ISOSORBIDE MONONITRATE ER 180 180 34 57
NOVOLOG FLEXPEN 178 156 35 194
NYSTATIN-TRIAMCINOLONE 171 171 36 140
INSULIN SYRINGE 169 142 37 187
IBUPROFEN 162 154 38 63
SANTYL 162 162 38 144
GLYBURIDE 159 144 R 40 66
ESCITALOPRAM OXALATE 154 152 41 82
CICLOPIROX 152 152 42 248
PREDNISONE 149 149 43 45
NITROGLYCERIN PATCH 145 145 44 171
TRAMADOL HCL 143 139 45 33
DIVALPROEX SODIUM 138 138 46 90
VALPROIC ACID 136 136 47 221
PANTOPRAZOLE SODIUM 135 133 48 44
CLOPIDOGREL 135 135 48 30
SPS 134 114 10 50 354
HALOPERIDOL 126 121 51 153
NYSTATIN 126 120 51 160
LIDODERM 121 120 53 74
SULFAMETHOXAZOLE-TRIMETHOPRIM 119 114 54 137
KLOR-CON M20 113 113 55 101
ALLOPURINOL 107 107 56 42
CELEBREX 107 95 56 75
CYMBALTA 107 107 56 56
RANITIDINE HCL 104 102 59 35
HYDRALAZINE HCL 102 102 60 99
POTASSIUM CHLORIDE 102 102 60 29
PAROXETINE HCL 101 101 62 62
CLONIDINE HCL 98 98 63 84
ALENDRONATE SODIUM 95 75 64 20
HUMALOG 94 78 65 246
AMITRIPTYLINE HCL 94 94 R 65 113
SPIRONOLACTONE 93 90 67 86
IPRATROPIUM-ALBUTEROL 92 91 68 110
METOCLOPRAMIDE HCL 91 91 69 150
NOVOFINE AUTOCOVER 91 87 69 361
MORPHINE SULFATE 87 86 S2 71 256
TRIAMCINOLONE ACETONIDE 86 83 72 138
HYDROCORTISONE VALERATE 86 86 72 275
FENTANYL 84 78 S2 74 102
BACLOFEN 84 54 74 123
TRAZODONE HCL 84 84 74 60
ENALAPRIL MALEATE 82 78 77 24
PLAVIX 81 81 78 41
SYMBICORT 80 80 79 114
FINASTERIDE 80 80 79 80
AZITHROMYCIN 78 75 81 40
SPIRIVA 78 72 81 36
EXELON 77 77 83 162
SEROQUEL 76 76 84 161
OXYBUTYNIN CHLORIDE ER 74 74 85 135
CEPHALEXIN 74 72 85 132
LAMOTRIGINE 73 49 87 232
MUPIROCIN 69 68 88 152
NOVOLOG 68 55 89 159
NAPROXEN 66 63 90 91
DIOVAN 64 63 91 26
DILTIAZEM ER 64 64 91 270
GLIPIZIDE 63 63 93 71
HYDROCORTISONE 62 59 94 208
DOXAZOSIN MESYLATE 61 61 95 127
LEVOFLOXACIN 61 60 95 108
NOVOLIN N 61 44 95 279
LIDOCAINE 61 61 95 186
HYDROXYZINE HCL 58 58 R 99 212
CIPROFLOXACIN HCL 56 54 100 85
CHLORHEXIDINE GLUCONATE 56 41 100 166
LUMIGAN 56 56 100 351
AMIODARONE HCL 55 53 103 277
SINGULAIR 51 47 104 64
NITROFURANTOIN 51 50 104 359
CRESTOR 51 51 104 15
OXYBUTYNIN CHLORIDE 50 50 107 189
ROPINIROLE HCL 50 50 107 143
JANUVIA 50 45 107 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.